Yue Li

Tianjin, 300384, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Seco-tanapartholide B ameliorates acute lung injury by covalently activating PKM2 and reprogramming glycolytic metabolism.

Seco-tanapartholide B ameliorates acute lung injury by covalently activating PKM2 and reprogramming glycolytic metabolism.

Journal: Bioorganic chemistry

Published: March 18, 2026

NSUN2-mediated m5C modification of E2F1 promotes lung adenocarcinoma progression via the RAD54L signaling axis.

NSUN2-mediated m5C modification of E2F1 promotes lung adenocarcinoma progression via the RAD54L signaling axis.

Journal: Respiratory research

Published: February 12, 2026

Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma.

Identification of biomarkers based on ubiquitin-correlated genes for predicting immune profile and drug sensitivity in lung adenocarcinoma.

Journal: Frontiers in pharmacology

Published: June 13, 2025

Ethanol extract of Sauropus spatulifolius and its active constituents attenuate LPS-induced acute lung injury via NF-κB inhibition and Nrf2 activation.

Ethanol extract of Sauropus spatulifolius and its active constituents attenuate LPS-induced acute lung injury via NF-κB inhibition and Nrf2 activation.

Journal: Food science and biotechnology

Published: April 09, 2025

Baliosperoid A attenuates lipopolysaccharide-induced acute lung injury by targeting SHP2 to inhibit inflammation and oxidative stress.

Baliosperoid A attenuates lipopolysaccharide-induced acute lung injury by targeting SHP2 to inhibit inflammation and oxidative stress.

Journal: Bioorganic chemistry

Published: September 11, 2024

Dehydrocostus Lactone Ameliorates LPS-Induced Acute Lung Injury by Inhibiting PFKFB3-Mediated Glycolysis.

Dehydrocostus Lactone Ameliorates LPS-Induced Acute Lung Injury by Inhibiting PFKFB3-Mediated Glycolysis.

Journal: Journal of cellular biochemistry

Published: April 28, 2024

Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy.

Exploring clinical factors to predict the survival of patients with resectable non-small cell lung cancer with neoadjuvant immunotherapy.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: January 30, 2024

LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.

LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.

Journal: Cellular & molecular biology letters

Published: May 08, 2022

Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).

Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).

Journal: Thoracic cancer

Published: July 15, 2021

Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis.

Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis.

Journal: Translational lung cancer research

Published: September 21, 2020

Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.

Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.

Journal: Thoracic cancer

Published: July 23, 2020

Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.

Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: February 25, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026